INCR
InterCure Ltd
$
1.460
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.460
Open
1.430
VWAP
1.42
Vol
66.85K
Mkt Cap
79.59M
Low
1.3963
Amount
95.10K
EV/EBITDA(TTM)
--
Total Shares
45.57M
EV
344.11M
EV/OCF(TTM)
--
P/S(TTM)
0.66
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Show More
Valuation Metrics
The current forward P/E ratio for InterCure Ltd (INCR.O) is 0.00, compared to its 5-year average forward P/E of -0.38. For a more detailed relative valuation and DCF analysis to assess InterCure Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-0.38
Current PE
0.00
Overvalued PE
0.79
Undervalued PE
-1.55
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.28
Current EV/EBITDA
1.15
Overvalued EV/EBITDA
12.56
Undervalued EV/EBITDA
-12.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Overvalued
5Y Average PS
1.46
Current PS
4.56
Overvalued PS
2.55
Undervalued PS
0.37
Financials
Annual
Quarterly
FY2023Q2
YoY :
+7.52%
102.44M
Total Revenue
FY2023Q2
YoY :
-62.19%
6.02M
Operating Profit
FY2023Q2
YoY :
-75.93%
3.73M
Net Income after Tax
FY2023Q2
YoY :
-70.59%
0.10
EPS - Diluted
FY2023Q1
YoY :
+1098.31%
-57.35M
Free Cash Flow
FY2023Q4
YoY :
-14.14%
30.47
Gross Profit Margin - %
FY2023Q4
YoY :
-458.12%
-17.87
Net Margin - %
FY2023Q4
YoY :
-100.00%
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
INCR News & Events
Events Timeline
2025-11-03 (ET)
2025-11-03
08:38:59
InterCure and Cannasoul Forge Strategic Investment and Collaboration Partnerships
2025-10-08 (ET)
2025-10-08
09:03:28
InterCure Announces 1H Revenue of NIS 130M, Up from NIS 126M Last Year
2025-09-19 (ET)
2025-09-19
08:51:16
InterCure Reveals Purchase of ISHI for 4.92 Million Common Shares
Sign Up For More Events
Sign Up For More Events
News
8.5
09-19BenzingaInterCure Joins High-End US Cannabis Market Through ISHI Agreement
8.5
09-19NewsfilterInterCure Reveals Strategic Purchase of ISHI, Gaining Access to Top U.S. Cannabis Technology and Brands
5.0
02-12Business InsiderInterCure names Alexander Rabinovich as Chairman, replacing Ehud Barak
Sign Up For More News
People Also Watch
IPSC
Century Therapeutics Inc
0.600
USD
+2.92%
EPIX
ESSA Pharma Inc
0
USD
-1.99%
LSBK
Lake Shore Bancorp Inc
14.100
USD
+2.03%
ANIX
Anixa Biosciences Inc
4.140
USD
+0.24%
OKUR
Onkure Therapeutics Inc
3.270
USD
-3.54%
CATO
Cato Corp
3.950
USD
+2.60%
CTM
Castellum Inc
1.310
USD
+11.97%
PBHC
Pathfinder Bancorp Inc (MARYLAND)
15.080
USD
+0.40%
GALT
Galectin Therapeutics Inc
6.000
USD
+3.27%
FAQ
What is InterCure Ltd (INCR) stock price today?
The current price of INCR is 1.46 USD — it has increased 4.29 % in the last trading day.
What is InterCure Ltd (INCR)'s business?
What is the price predicton of INCR Stock?
What is InterCure Ltd (INCR)'s revenue for the last quarter?
What is InterCure Ltd (INCR)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for InterCure Ltd (INCR)'s fundamentals?
How many employees does InterCure Ltd (INCR). have?